INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART)

Historical Holders from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
IART on Nasdaq
Shares outstanding
77,575,733
Price per share
$12.42
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
72,862,586
Total reported value
$1,043,959,806
% of total 13F portfolios
0%
Share change
-491,180
Value change
-$4,250,582
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
205
Price from insider filings
$13.13
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 13% $136,554,322 10,282,705 BlackRock, Inc. 30 Jun 2025
Rubric Capital Management LP 9.5% +58% $97,660,244 +$35,992,279 7,353,934 +58% Rubric Capital Management LP 30 Jun 2025
Invesco Ltd. 4.5% -16% $50,024,712 -$8,895,949 3,490,908 -15% Invesco Ltd. 30 Sep 2025
MORGAN STANLEY 4.3% $44,878,445 3,379,401 Morgan Stanley 30 Jun 2025
As of 30 Sep 2025, INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART) has 205 institutional shareholders filing 13F forms. They hold 72,862,586 shares. of 77,575,733 outstanding shares (94%) .

Top 25 institutional shareholders own 79% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
BlackRock, Inc. 13% 10,229,183 -1.2% 0% $146,584,192
Rubric Capital Management LP 9.9% 7,653,934 +4.1% 1.5% $109,680,874
VANGUARD GROUP INC 9.5% 7,379,127 -2.6% 0% $105,742,890
FULLER & THALER ASSET MANAGEMENT, INC. 5% 3,914,438 +0.56% 0.19% $56,093,904
MORGAN STANLEY 4.9% 3,824,662 -2.8% 0% $54,807,421
Invesco Ltd. 4.5% 3,490,908 -1.3% 0.01% $50,024,711
DIMENSIONAL FUND ADVISORS LP 4.1% 3,184,726 +9.2% 0.01% $45,634,196
STATE STREET CORP 3.6% 2,790,898 -1.3% 0% $39,993,568
PARADIGM CAPITAL MANAGEMENT INC/NY 3.3% 2,529,800 +16% 1.6% $36,252,034
GEODE CAPITAL MANAGEMENT, LLC 2% 1,548,221 -5.7% 0% $22,189,774
NEUBERGER BERMAN GROUP LLC 2% 1,535,184 +79% 0.02% $21,953,995
GOLDMAN SACHS GROUP INC 2% 1,532,334 -11% 0% $21,958,347
Soleus Capital Management, L.P. 1.9% 1,440,818 +3.8% 1.1% $20,646,922
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.8% 1,390,046 +14% 0% $19,919,359
WELLINGTON MANAGEMENT GROUP LLP 1.7% 1,321,275 -0.19% 0% $18,933,871
SYSTEMATIC FINANCIAL MANAGEMENT LP 1.4% 1,060,505 +0.34% 0.37% $15,197,049
J. Goldman & Co LP 1.2% 950,811 +170% 0.52% $13,625,122
Glenmede Investment Management, LP 1.1% 842,430 +23% 0.06% $12,072,021
NORTHERN TRUST CORP 1% 814,339 +9.6% 0% $11,669,478
DEERFIELD MANAGEMENT COMPANY, L.P. 1% 794,865 0% 0.17% $11,390,415
Kent Lake PR LLC 0.97% 752,086 5.5% $10,777,392
D. E. Shaw & Co., Inc. 0.81% 625,151 -6.5% 0.01% $8,958,414
BANK OF AMERICA CORP /DE/ 0.8% 624,080 -5.5% 0% $8,943,065
Invenomic Capital Management LP 0.76% 592,212 +7.2% 0.44% $8,486,398
JPMORGAN CHASE & CO 0.71% 551,732 -3.7% 0% $7,906,320

Institutional Holders of INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 929,679 $11,555,753 +$5,557,987 1,242.01% 7
2025 Q3 72,862,586 $1,043,959,806 -$4,250,582 1,433% 205
2025 Q2 73,128,875 $897,334,015 -$36,927,306 1,227% 208
2025 Q1 73,527,026 $1,616,421,998 +$95,408,346 2,199% 217
2024 Q4 69,307,219 $1,571,897,798 +$40,656,530 2,268% 219
2024 Q3 68,311,436 $1,241,129,046 -$132,335,985 1,817% 219
2024 Q2 71,001,710 $2,068,378,173 +$130,660,585 2,914% 236
2024 Q1 65,281,332 $2,312,824,268 -$84,395,187 3,545% 273
2023 Q4 514,424 $22,411,792 +$883,410 4,355% 3
2023 Q3 67,479,397 $2,577,066,857 -$20,941,421 3,819% 255
2023 Q2 68,152,781 $2,803,305,570 -$206,182,700 4,113% 270
2023 Q1 72,052,117 $4,136,235,350 -$119,921,164 5,741% 271
2022 Q4 74,044,821 $4,151,662,567 +$367,602,679 5,607% 268
2022 Q3 70,537,046 $2,988,591,589 +$3,104,787 4,236% 257
2022 Q2 72,146,812 $3,895,729,858 -$64,686,337 5,403.01% 268
2022 Q1 73,981,290 $4,754,268,205 -$195,587,823 6,426% 263
2021 Q4 76,197,532 $5,105,015,430 +$22,580,979 6,699.04% 261
2021 Q3 76,860,330 $5,264,568,858 +$135,178,425 6,848% 251
2021 Q2 74,789,442 $5,104,415,214 +$62,404,478 6,824% 259
2021 Q1 73,291,020 $5,063,574,402 -$13,170,524 6,908.99% 252
2020 Q4 73,108,202 $4,746,287,680 +$106,187,071 6,491.98% 239
2020 Q3 72,733,580 $3,434,003,702 +$24,605,724 4,721.97% 227
2020 Q2 72,219,818 $3,393,083,524 +$37,784,963 4,699% 258
2020 Q1 71,378,248 $3,188,358,669 +$35,388,466 4,466.97% 246
2019 Q4 70,167,103 $4,087,755,685 +$76,124,405 5,827.94% 270
2019 Q3 68,608,998 $4,120,673,027 -$76,375,295 6,006.91% 269
2019 Q2 70,389,850 $3,930,941,782 +$25,709,786 5,585% 256
2019 Q1 70,887,037 $3,949,711,245 -$17,359,991 5,571.99% 252
2018 Q4 70,556,960 $3,182,017,781 -$136,174,919 4,509.99% 237
2018 Q3 73,181,147 $4,820,265,048 +$97,787,830 6,586.98% 239
2018 Q2 72,057,265 $4,641,149,991 +$177,736,703 6,441% 252
2018 Q1 70,060,676 $3,869,006,380 -$42,253,161 5,533.98% 232
2017 Q4 71,381,479 $3,416,873,181 +$94,614,612 4,785.99% 216
2017 Q3 68,303,311 $3,446,680,688 +$125,941,790 5,047.95% 210
2017 Q2 65,647,552 $3,578,576,000 +$86,950,140 5,450.96% 218
2017 Q1 67,258,271 $2,833,749,699 +$1,502,754,633 4,212.95% 231
2016 Q4 33,908,022 $2,908,979,687 +$121,255,955 8,579% 207
2016 Q3 32,760,625 $2,700,677,668 +$59,584,464 8,254.98% 228
2016 Q2 33,433,531 $2,667,800,330 +$55,401,809 7,977.99% 205
2016 Q1 32,786,718 $2,207,891,120 +$101,813,552 6,735.96% 190
2015 Q4 31,272,052 $2,119,805,593 +$35,241,413 6,777.97% 179
2015 Q3 30,860,028 $1,837,708,938 +$217,764,444 5,954.98% 185
2015 Q2 26,835,429 $1,806,326,069 -$23,251,100 6,736.92% 184
2015 Q1 27,558,125 $1,698,249,280 +$73,531,746 6,165.01% 168
2014 Q4 26,419,505 $1,433,016,011 +$6,328,741 5,423% 156
2014 Q3 26,283,517 $1,304,706,409 +$5,503,127 4,963.93% 139
2014 Q2 26,157,284 $1,230,953,241 +$22,080,350 4,705.96% 142
2014 Q1 24,924,604 $1,146,200,055 +$13,975,206 4,599.01% 137